{
    "Trade/Device Name(s)": [
        "AutoSure Voice 3 Plus Blood Glucose Monitoring System",
        "AutoSure Plus Blood Glucose Test Strips"
    ],
    "Submitter Information": "Apex Biotechnology Corp.",
    "510(k) Number": "K120649",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113098"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "June 7, 2012",
    "Summary Letter Received Date": "June 8, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AutoSure Voice 3 Plus Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strips"
    ],
    "Document Summary": "FDA 510(k) summary for AutoSure Voice 3 Plus Blood Glucose Monitoring System and test strips for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for the quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, or palm for single-patient lay use in people with diabetes; not for diagnosis or screening of diabetes or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}